ea0029p703 | Diabetes | ICEECE2012
Zarina L.
, Tarasova L.
, Nikitina-Zake L.
, Kempa I.
, Cirse M.
, Klovins J.
, Geldnere K.
, Konrade I.
, Lejnieks A.
, Pirags V.
Background: Many patients with type 2 diabetes (T2D) are not reaching glycemic targets even by using different combinations of antidiabetic drugs, including insulin. On the other hand, intensified multidrug therapy is associated with increased risk of severe side effects and individualized selection of medication is essential. The aim of our study is to evaluate efficiency of personalized pharmacotherapy according to the genotype and phenotype of T2D patients.<p class="abs...